Ischemia Care Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Latest Deal Amount
-
$13M
- Investors
-
10
Ischemia Care General Information
Description
Developer of a blood testing and clinical decision support platform designed to improve diagnosis and care coordination in stroke and cardiovascular workflows. The company offers RNA (Ribonucleic Acid)-based diagnostics, a proprietary clinical dataset, and embedded decision support tools, enabling health systems and providers to reduce readmissions, lower care costs, and improve adherence to clinical guidelines.
Contact Information
Website
www.ischemiacare.comCorporate Office
- 347 South College Avenue
- Suite B
- Oxford, OH 45056
- United States
Corporate Office
- 347 South College Avenue
- Suite B
- Oxford, OH 45056
- United States
Ischemia Care Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | $13M | Cancelled | Restart | |||
| 12. Later Stage VC | 01-Sep-2022 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 15-May-2020 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Jun-2019 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 22-Dec-2017 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 12-Oct-2016 | Completed | Product In Beta Test | |||
| 7. Later Stage VC | 25-Sep-2014 | Completed | Product In Beta Test | |||
| 6. Later Stage VC (Series B3) | 01-Jan-2014 | Completed | Product In Beta Test | |||
| 5. Early Stage VC (Series B2) | 01-Feb-2013 | $330K | $1.64M | Completed | Product In Beta Test | |
| 4. Early Stage VC (Series B) | 01-Jul-2012 | $810K | $1.31M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ischemia Care Comparisons
Industry
Financing
Details
Ischemia Care Competitors (10)
One of Ischemia Care’s 10 competitors is Viz.ai, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Viz.ai | Venture Capital-Backed | San Francisco, CA | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Abbott Diagnostics | Failed Transaction (M&A) | Lake Forest, IL | ||||
| RapidAI | Venture Capital-Backed | Golden, CO | ||||
| Quanterix | Formerly PE-Backed | Billerica, MA |
Ischemia Care Patents
Ischemia Care Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230332236-A1 | Method for diagnosing stroke utilizing gene expression signatures | Pending | 08-Oct-2020 | ||
| WO-2022076275-A1 | Method for diagnosing stroke utilizing gene expression signatures | Inactive | 08-Oct-2020 | ||
| US-12716097-B2 | Biomarkers for the diagnosis of atrial fibrillation cause of stroke | Active | 13-Dec-2019 | ||
| US-20230002829-A1 | Biomarkers for the diagnosis of atrial fibrillation cause of stroke | Active | 13-Dec-2019 | ||
| US-20260327704-A1 | Biomarkers for the diagnosis of atrial fibrillation cause of stroke | Pending | 13-Dec-2019 | C12Q1/6883 |
Ischemia Care Signals
Ischemia Care Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| John Lilly Strategic Insights | Corporation | Minority | ||
| Lateral Capital Management | Venture Capital | Minority | ||
| MedTech Innovator | Accelerator/Incubator | Minority | ||
| Solas BioVentures | Venture Capital | Minority | ||
| Broadview Ventures | Venture Capital | Minority |
Ischemia Care FAQs
-
When was Ischemia Care founded?
Ischemia Care was founded in 2009.
-
Where is Ischemia Care headquartered?
Ischemia Care is headquartered in Oxford, OH.
-
What is the size of Ischemia Care?
Ischemia Care has 4 total employees.
-
What industry is Ischemia Care in?
Ischemia Care’s primary industry is Diagnostic Equipment.
-
Is Ischemia Care a private or public company?
Ischemia Care is a Private company.
-
What is the current valuation of Ischemia Care?
The current valuation of Ischemia Care is .
-
What is Ischemia Care’s current revenue?
The current revenue for Ischemia Care is .
-
How much funding has Ischemia Care raised over time?
Ischemia Care has raised $13.2M.
-
Who are Ischemia Care’s investors?
John Lilly Strategic Insights, Lateral Capital Management, MedTech Innovator, Solas BioVentures, and Broadview Ventures are 5 of 10 investors who have invested in Ischemia Care.
-
Who are Ischemia Care’s competitors?
Viz.ai, Medtronic, Abbott Diagnostics, RapidAI, and Quanterix are some of the 10 competitors of Ischemia Care.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process